HomeCompareEMBK vs MRK

EMBK vs MRK: Dividend Comparison 2026

EMBK yields 69.44% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMBK wins by $966.6K in total portfolio value
10 years
EMBK
EMBK
● Live price
69.44%
Share price
$2.88
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.02M
Annual income
$267,261.90
Full EMBK calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — EMBK vs MRK

📍 EMBK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMBKMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMBK + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EMBK pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMBK
Annual income on $10K today (after 15% tax)
$5,902.78/yr
After 10yr DRIP, annual income (after tax)
$227,172.62/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, EMBK beats the other by $218,575.90/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMBK + MRK for your $10,000?

EMBK: 50%MRK: 50%
100% MRK50/50100% EMBK
Portfolio after 10yr
$541.0K
Annual income
$138,687.84/yr
Blended yield
25.63%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EMBK
Analyst Ratings
1
Buy
2
Hold
Consensus: Hold
Altman Z
-4.0
Piotroski
1/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMBK buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMBKMRK
Forward yield69.44%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1.02M$57.7K
Annual income after 10y$267,261.90$10,113.78
Total dividends collected$871.5K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: EMBK vs MRK ($10,000, DRIP)

YearEMBK PortfolioEMBK Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$17,644$6,944.44$11,213$373.04+$6.4KEMBK
2$30,331$11,451.48$12,667$512.06+$17.7KEMBK
3$50,852$18,397.43$14,439$708.14+$36.4KEMBK
4$83,238$28,826.45$16,640$988.16+$66.6KEMBK
5$133,163$44,098.37$19,432$1,394.07+$113.7KEMBK
6$208,417$65,932.76$23,057$1,992.90+$185.4KEMBK
7$319,448$96,442.33$27,889$2,894.79+$291.6KEMBK
8$479,960$138,150.28$34,518$4,286.29+$445.4KEMBK
9$707,544$193,986.89$43,912$6,494.35+$663.6KEMBK
10$1,024,334$267,261.90$57,714$10,113.78+$966.6KEMBK

EMBK vs MRK: Complete Analysis 2026

EMBKStock

Embark Technology, Inc. develops self-driving software solutions for the trucking industry in the United States. Its solutions include Embark Driver, an autonomous trucking software; Embark Universal Interface, an interoperable self-driving stack that works across truck OEM platforms; and Embark Guardian, a cloud-based autonomous fleet management solution that gives carriers control over air updates, remote vehicle monitoring, remote vehicle assist, dispatching and access to real time data, such as weather and construction. The company was incorporated in 2016 and is headquartered in San Francisco, California.

Full EMBK Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this EMBK vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMBK vs SCHDEMBK vs JEPIEMBK vs OEMBK vs KOEMBK vs MAINEMBK vs JNJEMBK vs ABBVEMBK vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.